HAAH Automotive Holdings, a company that was formed by a group of auto industry executives and experts, has named Nicole Geenen as its new vice president of Service Operations for HAAH Automotive Holdings and Zotye USA.
HAAH Automotive Holdings chairman and CEO, Duke Hale, said, 'As we continue to build out the HAAH team, I couldn't be more excited to welcome Nicole to the HAAH and Zotye USA team.
Furthermore oncologists may soon be able to monitor the levels of HAAH
, as an indicator of remission or recurrence of disease.
HAAH is a cancer molecular marker that has been detected by immunohistochemical staining in a broad range of cancers; this marker was originally discovered at the Rhode Island Hospital / Brown University.
"We are excited about receiving notice of the issuance of the patent covering antibodies against HAAH, and particularly PAN-622, our all-human sequence monoclonal antibody against HAAH," noted Hossein Ghanbari, Ph.D., Chairman, CEO and CSO at Panacea Pharmaceuticals.
"HAAH is an excellent target for monoclonal antibody cancer therapeutics, and we have developed several high affinity antibodies against HAAH with good promise as cancer therapeutics," commented K.
Automotive Holdings chairman and CEO Duke Hale, said, 'HAAH
and Zotye USA are a disruptive force in the North American auto industry.
Human Aspartyl (Asparaginyl) Beta-Hydroxylase (HAAH) is an enzyme that modulates signaling factors such as Notch, and is over-expressed in malignant cells.
In vitro, Panacea has shown that monoclonal antibodies against HAAH inhibit cell growth in a dose-dependent fashion, inhibit cell motility more than 6-fold and reduce invasion from 26% to 0.1%.
is co-locating the headquarters of its wholly owned subsidiary, Zotye USA, in the same building.